{"id":501448,"date":"2021-06-07T16:08:03","date_gmt":"2021-06-07T20:08:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/"},"modified":"2021-06-07T16:08:03","modified_gmt":"2021-06-07T20:08:03","slug":"processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/","title":{"rendered":"Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET"},"content":{"rendered":"
\n

HANOVER, MD, June 07, 2021 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (\u201cProcessa\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing products to improve the survival and\/or quality of life for patients who have unmet medical needs, announced today that management will present at:<\/p>\n

\n LD Micro Virtual Investor Conference<\/strong>
\n
Date: June 9, 2021
Time: 1:30 p.m. ET \u2013 Track 4
Webcast:\u00a0https:\/\/ldmicrojune2021.mysequire.com<\/strong><\/a><\/p>\n

A live audio webcast and archive of the event presentation will be available using the webcast link above. For more information on the LD Micro Invitational XI, or to register for the event, please visit\u00a0https:\/\/ldmicrojune2021.mysequire.com\u00a0<\/strong><\/a><\/p>\n

\n About\u00a0<\/strong>
\n Processa<\/strong>
\n \u00a0Pharmaceuticals, Inc.<\/strong>\n <\/p>\n

The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and\/or quality of life. The Company uses these criteria for selection to further develop its pipeline programs to achieve high-value milestones effectively and efficiently. Active clinical pipeline programs include: PCS6422 (metastatic colorectal cancer and breast cancer), PCS499 (ulcerative necrobiosis lipoidica) and PCS12852 (GI motility\/gastroparesis). The members of the Processa development team have been involved with more than 30 drug approvals by the FDA (including drug products targeted to orphan disease conditions) and more than 100 FDA meetings throughout their careers. For more information, visit the company\u2019s website at\u00a0www.ProcessaPharma.com\u00a0<\/strong><\/a>.<\/p>\n

\n Forward-Looking Statements<\/strong>\n <\/p>\n

This release contains forward-looking statements. The statements in this press release that are not purely historical are forward-looking statements which involve risks and uncertainties. Actual future performance outcomes and results may differ materially from those expressed in forward-looking statements. Please refer to the registration statement relating to the securities being sold in this offering, which identifies important risk factors which could cause actual results to differ from those contained in the forward-looking statements.<\/p>\n

For More Information:\u00a0
Michael Floyd\u00a0
mfloyd@processapharma.com\u00a0<\/strong><\/a>
301-651-4256<\/p>\n

James Carbonara\u00a0
Hayden IR\u00a0
(646) 755-7412\u00a0
james@haydenir.com\u00a0<\/strong><\/a><\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

HANOVER, MD, June 07, 2021 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (\u201cProcessa\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing products to improve the survival and\/or quality of life for patients who have unmet medical needs, announced today that management will present at: LD Micro Virtual Investor Conference Date: June 9, 2021Time: 1:30 p.m. ET \u2013 Track 4Webcast:\u00a0https:\/\/ldmicrojune2021.mysequire.com A live audio webcast and archive of the event presentation will be available using the webcast link above. For more information on the LD Micro Invitational XI, or to register for the event, please visit\u00a0https:\/\/ldmicrojune2021.mysequire.com\u00a0 About\u00a0 Processa \u00a0Pharmaceuticals, Inc. The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical … <\/p>\n

Continue reading “Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-501448","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nProcessa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HANOVER, MD, June 07, 2021 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (\u201cProcessa\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing products to improve the survival and\/or quality of life for patients who have unmet medical needs, announced today that management will present at: LD Micro Virtual Investor Conference Date: June 9, 2021Time: 1:30 p.m. ET \u2013 Track 4Webcast:\u00a0https:\/\/ldmicrojune2021.mysequire.com A live audio webcast and archive of the event presentation will be available using the webcast link above. For more information on the LD Micro Invitational XI, or to register for the event, please visit\u00a0https:\/\/ldmicrojune2021.mysequire.com\u00a0 About\u00a0 Processa \u00a0Pharmaceuticals, Inc. The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical … Continue reading "Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-07T20:08:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1MDE2OCM0MjMxMzE0IzUwMDA0NjUzNQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET\",\"datePublished\":\"2021-06-07T20:08:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\\\/\"},\"wordCount\":333,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1MDE2OCM0MjMxMzE0IzUwMDA0NjUzNQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\\\/\",\"name\":\"Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1MDE2OCM0MjMxMzE0IzUwMDA0NjUzNQ==\",\"datePublished\":\"2021-06-07T20:08:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1MDE2OCM0MjMxMzE0IzUwMDA0NjUzNQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1MDE2OCM0MjMxMzE0IzUwMDA0NjUzNQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/","og_locale":"en_US","og_type":"article","og_title":"Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET - Market Newsdesk","og_description":"HANOVER, MD, June 07, 2021 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (\u201cProcessa\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing products to improve the survival and\/or quality of life for patients who have unmet medical needs, announced today that management will present at: LD Micro Virtual Investor Conference Date: June 9, 2021Time: 1:30 p.m. ET \u2013 Track 4Webcast:\u00a0https:\/\/ldmicrojune2021.mysequire.com A live audio webcast and archive of the event presentation will be available using the webcast link above. For more information on the LD Micro Invitational XI, or to register for the event, please visit\u00a0https:\/\/ldmicrojune2021.mysequire.com\u00a0 About\u00a0 Processa \u00a0Pharmaceuticals, Inc. The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical … Continue reading \"Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-07T20:08:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1MDE2OCM0MjMxMzE0IzUwMDA0NjUzNQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET","datePublished":"2021-06-07T20:08:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/"},"wordCount":333,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1MDE2OCM0MjMxMzE0IzUwMDA0NjUzNQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/","name":"Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1MDE2OCM0MjMxMzE0IzUwMDA0NjUzNQ==","datePublished":"2021-06-07T20:08:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1MDE2OCM0MjMxMzE0IzUwMDA0NjUzNQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1MDE2OCM0MjMxMzE0IzUwMDA0NjUzNQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-to-present-at-ld-micro-virtual-investor-conference-on-june-9-2021-at-130pm-et\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/501448","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=501448"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/501448\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=501448"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=501448"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=501448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}